Total Payments
$66,836
2024 Payments
$21.95
Companies
16
Transactions
215
Medicare Patients
1,027
Medicare Billing
$51,203
Payment Breakdown by Category
Research$60,420 (90.4%)
Education$3,617 (5.4%)
Food & Beverage$2,799 (4.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $60,420 | 9 | 90.4% |
| Education | $3,617 | 7 | 5.4% |
| Food and Beverage | $2,799 | 199 | 4.2% |
Payments by Type
Research
$60,420
9 transactions
General
$6,416
206 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NEUROPACE, INC. | $64,020 | 13 | $0 (2018) |
| Sunovion Pharmaceuticals Inc. | $1,423 | 106 | $0 (2020) |
| Supernus Pharmaceuticals, Inc. | $946.03 | 72 | $0 (2021) |
| EISAI INC. | $114.15 | 6 | $0 (2019) |
| UCB, Inc. | $54.94 | 2 | $0 (2018) |
| Amgen Inc. | $46.86 | 3 | $0 (2019) |
| Greenwich Biosciences, Inc. | $43.00 | 2 | $0 (2021) |
| Lundbeck LLC | $41.27 | 2 | $0 (2018) |
| ABBVIE INC. | $38.05 | 2 | $0 (2024) |
| Biogen, Inc. | $22.34 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $21.95 | 1 | ABBVIE INC. ($21.95) |
| 2022 | $16.10 | 1 | ABBVIE INC. ($16.10) |
| 2021 | $75.73 | 4 | Greenwich Biosciences, Inc. ($26.09) |
| 2020 | $276.73 | 25 | Sunovion Pharmaceuticals Inc. ($217.75) |
| 2019 | $705.37 | 56 | Sunovion Pharmaceuticals Inc. ($364.56) |
| 2018 | $7,316 | 55 | NEUROPACE, INC. ($6,540) |
| 2017 | $58,424 | 73 | NEUROPACE, INC. ($57,480) |
All Payment Transactions
215 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 02/29/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.95 | General |
| Category: NEUROSCIENCE | ||||||
| 10/03/2022 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $16.10 | General |
| Category: HYPERHYDROSIS | ||||||
| 09/27/2021 | Biogen, Inc. | SPINRAZA (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: NEUROLOGY | ||||||
| 09/24/2021 | NATUS MEDICAL INCORPORATED | — | Food and Beverage | Cash or cash equivalent | $11.05 | General |
| 04/28/2021 | Supernus Pharmaceuticals, Inc. | TROKENDI XR (Drug), OXTELLAR XR | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: AED | ||||||
| 04/20/2021 | Greenwich Biosciences, Inc. | Epidiolex (Drug) | Food and Beverage | In-kind items and services | $26.09 | General |
| Category: Neurology | ||||||
| 09/28/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.64 | General |
| Category: CNS | ||||||
| 09/21/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: CNS | ||||||
| 09/10/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: CNS | ||||||
| 08/25/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.72 | General |
| Category: CNS | ||||||
| 07/27/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: CNS | ||||||
| 07/15/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: CNS | ||||||
| 07/09/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: CNS | ||||||
| 07/01/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $17.67 | General |
| Category: CNS | ||||||
| 06/25/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: CNS | ||||||
| 06/10/2020 | Supernus Pharmaceuticals, Inc. | OXTELLAR XR (Drug) | Food and Beverage | Cash or cash equivalent | $14.54 | General |
| Category: AED | ||||||
| 06/09/2020 | Acorda Therapeutics, Inc | INBRIJA (Drug) | Food and Beverage | Cash or cash equivalent | $12.06 | General |
| Category: PARKINSONS DISEASE | ||||||
| 06/02/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $16.32 | General |
| Category: CNS | ||||||
| 05/20/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $10.33 | General |
| Category: CNS | ||||||
| 05/13/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $9.92 | General |
| Category: CNS | ||||||
| 05/06/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $12.15 | General |
| Category: CNS | ||||||
| 04/01/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $6.04 | General |
| Category: CNS | ||||||
| 03/09/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.86 | General |
| Category: CNS | ||||||
| 03/04/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $5.54 | General |
| Category: CNS | ||||||
| 02/26/2020 | Sunovion Pharmaceuticals Inc. | APTIOM (Drug) | Food and Beverage | In-kind items and services | $2.60 | General |
| Category: CNS | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| RNS System Long-term Treatment Clinical Investigation | NEUROPACE, INC. | $57,480 | 6 |
| RNS Long Term Trmt Clin Trial | NEUROPACE, INC. | $2,940 | 3 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 79 | 86 | $10,400 | $3,524 |
| 2022 | 2 | 89 | 101 | $12,309 | $3,747 |
| 2021 | 6 | 264 | 279 | $49,380 | $11,347 |
| 2020 | 10 | 595 | 649 | $131,152 | $32,586 |
Total Patients
1,027
Total Services
1,115
Medicare Billing
$51,203
Procedure Codes
20
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 65 | 72 | $7,992 | $2,726 | 34.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 14 | 14 | $2,408 | $797.24 | 33.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 73 | 83 | $9,213 | $2,754 | 29.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 16 | 18 | $3,096 | $992.65 | 32.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 115 | 128 | $14,208 | $3,756 | 26.4% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2021 | 65 | 66 | $16,434 | $2,878 | 17.5% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Facility | 2021 | 36 | 37 | $10,212 | $2,310 | 22.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 18 | 18 | $3,096 | $1,066 | 34.4% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 18 | 18 | $3,150 | $802.80 | 25.5% |
| 95812 | Measurement of brain wave (eeg) activity, 41-60 minutes | Facility | 2021 | 12 | 12 | $2,280 | $535.20 | 23.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 193 | 216 | $23,976 | $6,373 | 26.6% |
| 95813 | Measurement of brain wave activity (eeg) extended monitoring, 61-119 minutes | Facility | 2020 | 89 | 94 | $25,944 | $6,298 | 24.3% |
| 95819 | Measurement and recording of brain wave (eeg) activity, awake and asleep | Facility | 2020 | 130 | 133 | $33,117 | $6,051 | 18.3% |
| 95720 | Continuous measurement of brain wave activity with video (veeg), 12-26 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 12 | 28 | $14,280 | $4,629 | 32.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 55 | 61 | $10,492 | $2,968 | 28.3% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 58 | 59 | $10,325 | $2,576 | 24.9% |
| 95718 | Continuous measurement of brain wave activity with video (veeg), 2-12 hours, with health care professional analysis, interpretation and report | Facility | 2020 | 12 | 12 | $3,948 | $1,176 | 29.8% |
| 95812 | Measurement of brain wave (eeg) activity, 41-60 minutes | Facility | 2020 | 24 | 24 | $4,560 | $1,055 | 23.1% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 11 | 11 | $2,695 | $977.53 | 36.3% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Facility | 2020 | 11 | 11 | $1,815 | $482.62 | 26.6% |
About Dr. Anthony Murro, MD
Dr. Anthony Murro, MD is a Neurology healthcare provider based in Augusta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/30/2006. The National Provider Identifier (NPI) number assigned to this provider is 1740399781.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Anthony Murro, MD has received a total of $66,836 in payments from pharmaceutical and medical device companies, with $21.95 received in 2024. These payments were reported across 215 transactions from 16 companies. The most common payment nature is "" ($60,420).
As a Medicare-enrolled provider, Murro has provided services to 1,027 Medicare beneficiaries, totaling 1,115 services with total Medicare billing of $51,203. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Augusta, GA
- Active Since 08/30/2006
- Last Updated 01/04/2019
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1740399781
Products in Payments
- RNS System (Device) $64,020
- APTIOM (Drug) $1,423
- OXTELLAR XR (Drug) $622.66
- TROKENDI XR (Drug) $312.96
- Fycompa (Drug) $114.15
- Briviact (Drug) $54.94
- Aimovig (Biological) $46.86
- Epidiolex (Drug) $43.00
- NORTHERA (Drug) $24.29
- SPINRAZA (Biological) $22.34
- QULIPTA (Drug) $21.95
- QUDEXY XR Topiramate Extended Release Capsules (Drug) $21.60
- ONFI (Drug) $16.98
- BOTOX (Biological) $16.10
- Gamunex-C (Biological) $16.07
- ELIQUIS (Drug) $13.52
- INBRIJA (Drug) $12.06
- AIMOVIG (Biological) $12.01
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Augusta
John Morgan, Md, MD
Neurology — Payments: $745,663
Neurology $745,663
Alexis Shaefer, M.d, M.D
Neurology — Payments: $251,468
Neurology $251,468
Dr. John Henson, Md, MD
Neurology — Payments: $71,522
Neurology $71,522
Dr. Colin Mcleod, M.d, M.D
Neurology — Payments: $44,607
Neurology $44,607
Dr. Bryan Ho, M.d, M.D
Neurology — Payments: $29,785
Neurology $29,785
Dr. Julie Kurek
Neurology — Payments: $27,870
Neurology $27,870